Intensified glucose control in type 2 diabetes--whose agenda?

Lancet. 2011 Apr 9;377(9773):1220-2. doi: 10.1016/S0140-6736(10)61112-9. Epub 2010 Nov 18.
No abstract available

MeSH terms

  • Blood Glucose / metabolism*
  • Blood Glucose Self-Monitoring
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / prevention & control*
  • Diabetes Complications / blood
  • Diabetes Complications / prevention & control*
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Drug Industry
  • Glycated Hemoglobin A / metabolism*
  • Humans
  • Hyperglycemia / complications*
  • Hyperglycemia / drug therapy
  • Hypoglycemic Agents / administration & dosage*
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / economics
  • Mass Screening
  • Practice Guidelines as Topic
  • Quality of Life
  • Research Support as Topic
  • United Kingdom
  • United States

Substances

  • Blood Glucose
  • Glycated Hemoglobin A
  • Hypoglycemic Agents